By Dr. Rajat Kandhari — MD Dermatology (Gold Medalist), MSc Non-Surgical Facial Aesthetics (Distinction, UK), Medical Director, Dr. Kandhari’s Skin Clinic, Greater Kailash Part-1, South Delhi
Pigmentation is one of the most common skin concerns I see at our Greater Kailash clinic — and one of the most frequently mismanaged. Patients arrive after months of using brightening creams that have faded the surface colour temporarily without addressing the cause, or after laser treatments elsewhere that have triggered a rebound darkening worse than the original patch. Understanding why requires understanding the biology of melasma treatment in Delhi and why Indian skin — particularly Fitzpatrick type IV–VI — behaves so differently from the lighter skin types on which most of these treatments were originally developed.
Getting pigmentation treatment in Delhi right is not simply a matter of applying the correct cream or booking the right laser. It requires an accurate diagnosis of the type of pigmentation, an understanding of its drivers, and a treatment protocol that targets those drivers without triggering the melanocyte over-response that worsens things. This is where most single-treatment approaches fail.
The Different Types of Pigmentation — and Why the Distinction Matters
Melasma is the most complex and recurrent form of facial pigmentation. It presents as symmetrical brown or greyish patches — typically on the cheeks, upper lip, forehead, and chin — and is driven by a combination of UV exposure, oestrogen pigmentation (hormonal influence from oral contraceptives, pregnancy, or hormonal fluctuations), and chronic inflammation. The melanocytes in melasma-affected skin are not just overactive — they are structurally altered, with more dendrites and more melanin transfer activity than normal skin. This is why melasma has a high recurrence rate: the underlying cellular change persists even after the visible pigment is cleared.
Post-inflammatory hyperpigmentation (PIH) follows skin injury — acne, a peel that was too aggressive, a laser at incorrect settings, even a scratch. The melanocyte responds to inflammation by producing excess melanin as a protective response. On Fitzpatrick IV–VI skin, this response is dramatically more pronounced than on lighter skin — a minor inflammatory trigger can produce a dark mark that takes months to fade. This is why so many well-intentioned aggressive treatments on Indian skin produce more PIH than they resolve.
Lentigines (sun spots or age spots) are discrete, flat, well-defined brown marks caused by UV-induced melanin synthesis in clusters of overactive melanocytes. They respond well to targeted laser treatment — specifically QS NdYAG — because the energy can be precisely focused on the pigmented lesion without over-treating surrounding skin.
Drug-induced pigmentation and lichen planus pigmentosus are less common but often misdiagnosed as melasma. A careful history and clinical examination is essential to distinguish them — because the treatment approach differs significantly.
Why Standard Brightening Treatments Often Fail on Indian Skin
inhibitor cream (hydroquinone, kojic acid, arbutin), applied twice daily — addresses melanin synthesis at the enzyme level. It reduces new melanin production but does not accelerate clearance of existing pigment, does not address the hormonal or UV driver, and produces no structural change in the overactive melanocyte. Improvement is visible but slow, and recurrence upon stopping is the rule rather than the exception in melasma.
More critically, creams alone cannot address deep dermal pigmentation — the grey-brown component of melasma that sits in the dermis, not just the epidermis. This deeper fraction requires wavelengths of energy that penetrate to the dermis — specifically the QS NdYAG wavelength at 1064nm — or treatments that stimulate dermal remodelling through other mechanisms.
What Actually Works: The Clinical Approach at Our South Delhi Clinic
QS NdYAG Laser Toning
The QS NdYAG laser at 1064nm is the most clinically validated laser treatment for melasma treatment and general pigmentation on Indian skin. At low fluence in toning mode, it selectively targets melanin deposits in both the epidermis and dermis — fragmenting pigment granules that are then cleared by the immune system — without generating the heat that risks triggering post-inflammatory hyperpigmentation in darker skin. A series of six to eight sessions spaced two weeks apart, combined with topical tyrosinase inhibitor therapy and strict sun protection, produces consistent lightening of both epidermal and dermal melasma components. Details are on our QS NdYAG Laser page.
Brilliance Peels
Medical-grade dark spots treatment using mandelic acid, kojic acid, lactic acid, and phytic acid combinations — formulated specifically for Indian skin tolerances — provides effective epidermal turnover and tyrosinase inhibition through the peel cycle. Mandelic acid is particularly well-suited to darker skin types because its larger molecular size means slower penetration, reducing the irritation that triggers PIH. A structured Brilliance Peel programme of four to six sessions alongside topical maintenance produces meaningful improvement in overall skin tone, surface pigmentation, and post-acne marks without the downtime of ablative treatments. See our Brilliance Peels page.
PDRN Boosters
Polynucleotide (PDRN) boosters — injected intradermally — work through a different mechanism: they stimulate the A2A adenosine receptor pathway, activating DNA repair mechanisms, reducing inflammatory activity in the dermis, and promoting tissue regeneration. In the context of melasma, PDRN reduces the chronic inflammatory micro-environment that sustains melanocyte overactivity — addressing the driver, not just the symptom. Combined with QS NdYAG laser toning, PDRN boosters significantly improve the durability of melasma treatment outcomes. Details on our PDRN Boosters page.
Dermafrac
For patients with both superficial pigmentation and textural concerns, Dermafrac — a simultaneous microneedling and infusion device — delivers active brightening serums (containing kojic acid, arbutin, and tranexamic acid) directly into the dermis via a vacuum-assisted microneedling head. The combination of controlled micro-injury and targeted infusion bypasses the epidermal barrier that limits topical cream penetration, delivering active ingredients precisely where the melanocytes are. See our Dermafrac page.
The Critical Role of Sun Protection in Pigmentation Treatment
No pigmentation treatment programme works without rigorous sun protection — and in Delhi, this is not a seasonal recommendation. UV levels in the city are significant for most of the year, and UV-driven melanin synthesis is an active, ongoing process that can overwhelm treatment gains rapidly. Patients on active melasma treatment south delhi programmes are prescribed broad-spectrum SPF 50+ sunscreen, counselled on reapplication every two to three hours when outdoors, and advised on protective clothing and behavioural sun avoidance. Without this, clinical treatments provide only temporary gains.
The hormonal driver in oestrogen pigmentation also requires attention. For patients whose melasma is significantly driven by oral contraceptives, a discussion about alternative contraceptive options may be part of the treatment plan. This is a clinical conversation, not a lifestyle recommendation — and it makes the difference between manageable melasma and melasma that relapses every cycle
Combining Treatments: Why a Protocol Outperforms Any Single Approach
The most effective skin brightening delhi results I see in clinic come from protocol-based treatment — not a single modality. A typical melasma protocol at our clinic combines: strict topical priming with tyrosinase inhibitor agents for four weeks before any laser; a series of QS NdYAG toning sessions at two-week intervals; adjunct PDRN booster treatments interspersed through the laser series; and a maintenance peel programme to sustain clearance and prevent early recurrence. All stages are coordinated with SPF compliance monitoring.
For patients with both pigmentation and skin quality concerns — dull tone, fine texture irregularity — the Dermafrac protocol is integrated into the treatment plan. The outcome is not just cleared pigmentation but improved overall skin radiance and tone uniformity, which is a more meaningful result for most patients.
For a pigmentation assessment and personalised treatment plan, book a consultation at Dr. Rajat Kandhari’s clinic — S-79, Greater Kailash Part-1, South Delhi. Open Monday to Saturday, 9am to 8pm. Call or WhatsApp: +91 9315479193.
Frequently Asked Questions
Q1. What is the best treatment for melasma on Indian skin?
A combination protocol is most effective: topical tyrosinase inhibitor priming, QS NdYAG laser toning for both epidermal and dermal pigment, PDRN boosters to reduce the inflammatory driver, and structured sun protection. No single treatment clears melasma reliably on Fitzpatrick type IV–VI skin — the multi-modality approach addresses the condition at all levels simultaneously.
Q2. Can laser treatment worsen pigmentation on dark skin?
Yes, if the wrong laser or settings are used. High-fluence ablative lasers on Indian skin carry a significant risk of triggering post-inflammatory hyperpigmentation. QS NdYAG at low fluence in toning mode is specifically well-suited to darker skin types because it targets melanin selectively without generating the heat response that causes PIH. Correct patient selection and appropriate settings are essential.
Q3. How many sessions of QS NdYAG laser are needed for melasma?
Typically six to eight sessions at two-week intervals for visible improvement. Maintenance sessions may be required every two to three months to prevent recurrence, particularly for patients with a strong hormonal driver.
Q4. Why does melasma come back after treatment?
Melasma recurs because the underlying melanocyte alteration persists — the cells remain more reactive to UV and hormonal signals than normal skin. Treatment clears the current pigment load but does not permanently normalise the cellular response. Long-term management through maintenance treatments and consistent sun protection is the most effective strategy for sustained control rather than expecting a permanent cure.
Q5. Is there a treatment specifically for hormonal pigmentation?
Yes. Oestrogen pigmentation — melasma driven by oral contraceptives, pregnancy, or hormonal fluctuations — requires a treatment plan that acknowledges the hormonal driver. This may include a conversation about contraceptive alternatives, as well as topical and laser treatments that specifically target the overactive melanocytes rather than just surface pigment. PDRN boosters are particularly useful for reducing the dermal inflammatory environment that sustains hormonally driven melasma.
Q6. How long does it take to see results from pigmentation treatment?
Surface pigmentation typically shows meaningful lightening within four to six weeks of starting a topical and peel programme. QS NdYAG laser improvement accumulates over the treatment series, with visible change by sessions three to four. Deeper dermal melasma components take longer — twelve to sixteen weeks of consistent treatment. Hormonal melasma responds more slowly and requires longer maintenance.
Q7. Where is the clinic located?
S-79, Greater Kailash Part-1, New Delhi 110048. Accessible from south delhi neighbourhoods including Hauz Khas, Defence Colony, Lajpat Nagar, Malviya Nagar, Saket, and Green Park. Open Monday to Saturday, 9am to 8pm. +91 9315479193.